Skip to main content

Advertisement

Table 3 WPAI:UC scores for the acute phase sample at acute phase visits

From: Changes in health-related quality of life and work-related outcomes for patients with mild-to-moderate ulcerative colitis receiving short-term and long-term treatment with multimatrix mesalamine: a prospective, open-label study

   Baseline Week 3 Week 8 Post hoc comparisons (Bonferroni-adjusted P [α/3])
N LS Mean SE LS Mean SE LS Mean SD P Baseline vs. Week 3 Baseline vs. Week 8 Week 3 vs. Week 8
Absenteeism 367 13.0 1.35 6.6 1.03 4.5 0.80 0.1341
Presenteeism 376 35.9 1.37 21.2 1.15 16.7 1.19
Overall work impairment 365 42.0 1.60 25.4 1.42 19.8 1.39
Activity impairment 579 41.5 1.12 26.2 1.02 19.3 1.02
  1. LS least squares, SE standard error, WPAI:UC Work Productivity and Activity Impairment questionnaire for ulcerative colitis
  2. Findings for each outcome are based on mixed-effects models for repeated measures with subject as a random effect and visit as a fixed effect
  3. Week 8 includes early withdrawal visits during the acute phase
  4. P < 0.001